Docs Who Lift 1st longer term tirzepatide study (3 years)
14 snips
Nov 14, 2024 Discover the latest three-year study on tirzepatide, revealing its impact on weight loss and the challenges of maintaining it long-term. Dive into the side effects like nausea and pancreatitis, but see how they taper off over time. Uncover the potential of semaglutide in easing knee pain for those with osteoarthritis. Enjoy some humorous political musings, imagining a 'buff doctor' running for office while blending health and society's perceptions. It's a mix of science, laughter, and insights into modern weight management!
AI Snips
Chapters
Transcript
Episode notes
Tirzepatide vs. Semaglutide
- Tirzepatide is similar to semaglutide but causes more weight loss.
- It works by acting as a GLP-1/GIP co-agonist, impacting weight loss.
Tirzepatide Long-Term Weight Loss
- In a 3-year study, those on tirzepatide maintained weight loss, even with increased appetite.
- Placebo group maintained a 2% weight loss, while tirzepatide groups lost 15-23%.
Weight Regain After Stopping Tirzepatide
- After stopping tirzepatide, participants regained 7% of their body weight in 17 weeks.
- This rapid regain suggests the need for long-term medication use for sustained weight management.